US Representative

Trent Kelly 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 6)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3774

Introduced
5/31/23  
Refer
5/31/23  
Report Pass
10/19/23  
SHIP Act Stop Harboring Iranian Petroleum Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3792

Introduced
6/1/23  
U.S.-Israel Partnership and Abraham Accords Enhancement Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB384

Introduced
1/17/23  
Refer
1/17/23  
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3852

Introduced
6/6/23  
Create Accountable Respectful Environments (CARE) for Children Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3940

Introduced
6/9/23  
Neighborhood Homes Investment Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3952

Introduced
6/9/23  
Refer
6/9/23  
To limit the flags that may be flown over a facility of the Department of Veterans Affairs.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB398

Introduced
1/20/23  
Refer
1/20/23  
Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB407

Introduced
1/20/23  
Refer
1/20/23  
Protect the UNBORN (Undo the Negligent Biden Orders Right Now) Act or the Protect the UNBORN Act This bill prohibits federal implementation of and funding for specified executive orders that address access to reproductive health care services, including services related to pregnancy or the termination of a pregnancy.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4118

Introduced
6/14/23  
Department of Defense Student Financial Literacy Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4167

Introduced
6/15/23  
Refer
6/15/23  
Refer
6/16/23  
Protecting America’s Distribution Transformer Supply Chain Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4175

Introduced
6/15/23  
Refer
6/15/23  
REPO for Ukrainians Act Rebuilding Economic Prosperity and Opportunity for Ukrainians Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB421

Introduced
1/20/23  
Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4220

Introduced
6/20/23  
Dental Care for Our Troops Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4221

Introduced
6/20/23  
Healthcare for Our Troops Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4244

Introduced
6/21/23  
Servicemember Enrollment and Readmission for Valuable Education Act SERVE Act